AVNS

Avanos Medical Inc

AVNS, USA

Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; OrthogenRx knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

https://avanos.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
AVNS
stock
AVNS

Multi Factor Analysis Ranks ANI Integrated Services Limited as Strong Buy - Mid Cap Growth Trends & Low Cost Portfolio Growth Bollywood Helpline

Read more →
AVNS
stock
AVNS

New Strong Sell Stocks for Dec. 17 Yahoo Finance

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

HOLD

Target Price:

$14

Analyst Picks

Strong Buy

0

Buy

0

Hold

1

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

0.71

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-0.18 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-0.13 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

3.94 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very High

0.37

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 72.92% of the total shares of Avanos Medical Inc

1.

BlackRock Inc

(14.7176%)

since

2025/06/30

2.

Vanguard Group Inc

(9.6221%)

since

2025/06/30

3.

T. Rowe Price Investment Management,Inc.

(8.6127%)

since

2025/06/30

4.

Dimensional Fund Advisors, Inc.

(5.5559%)

since

2025/06/30

5.

Armistice Capital, LLC

(4.3877%)

since

2025/06/30

6.

State Street Corp

(4.1324%)

since

2025/06/30

7.

Brown Advisory Holdings Inc

(3.8981%)

since

2025/06/30

8.

Paradice Investment Management LLC

(2.7107%)

since

2025/06/30

9.

ExodusPoint Capital Management, LP

(2.6894%)

since

2025/06/30

10.

D. E. Shaw & Co LP

(2.5687%)

since

2025/06/30

11.

Geode Capital Management, LLC

(2.3146%)

since

2025/06/30

12.

Morgan Stanley - Brokerage Accounts

(1.8502%)

since

2025/06/30

13.

Tributary Capital Management, LLC

(1.7471%)

since

2025/06/30

14.

Charles Schwab Investment Management Inc

(1.4321%)

since

2025/06/30

15.

Qube Research & Technologies

(1.3478%)

since

2025/06/30

16.

AQR Capital Management LLC

(1.2069%)

since

2025/06/30

17.

Clark Estates Inc

(1.0643%)

since

2025/06/30

18.

Northern Trust Corp

(1.0562%)

since

2025/06/30

19.

Pacer Advisors, INC.

(1.0291%)

since

2025/06/30

20.

J. Goldman & Co LP

(0.9751%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

No earnings data available.

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Strong Deep Value(7)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(3)
Economic Moat
Wide Moat Company(6.3)
GARP
Fair GARP(4)
Growth
Weak Growth Prospect(2.5)
Momentum
No Momentum(3)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
Moderate Quality(6)
Value
Fair Value(5.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.